Can we make use of our organoid pipeline to precise treatment selection of NMIBC patients? Excited to conduct the GAIN-INST trial with a great scientific-clinical team @MariannKruithof @AbtDominik@je_bla@martademenna#SpitalzentrumBiel@unibern
https://t.co/fqF5TYUCF3
@Markuseckstein3 on bladder tumor subtype commitment occurring in CIS driven by key signaling pathways including ECM remodeling - may this observation be attributed to certain levels of tumor scarring? @Uroweb#EAU21 Also, great job by @JoshMeeks and @Roland3097 on the hosting!
A break on summer off for attending #eau20 and exchanging experiences in #bladdercancer. Great job of @uroweb allowing us to met virtually on #covi̇d19 era! Thanks!!!
We’ve decided to hold our annual IBCN meeting ‘virtual’ on Saturday Oct 17th, 2020 starting at 1500 CET featuring keynote speakers @Dan_Theodorescu and Francois Radvanyi. Submit your abstracts before August 1. Further details including registration link coming soon!
Now accepting abstracts for the 2019 Annual IBCN meeting
October 3 – 5, 2019 in Aarhus, Denmark. Abstract Deadline: July 1st, 2019. Please visit https://t.co/vvatvk6tnZ for abstract submission information. #IBCN2019@pcvblack@UroDocAsh@Roland3097@SWilliams_MD